Author:
Wu Chunchun,Li Mengna,Meng Hanbing,Liu Yukun,Niu Weihong,Zhou Yao,Zhao Ran,Duan Yumei,Zeng Zhaoyang,Li Xiaoling,Li Guiyuan,Xiong Wei,Zhou Ming
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference62 articles.
1. Abderrahman, B., and Jordan, V.C. (2018). Successful targeted therapies for breast cancer: the Worcester Foundation and future opportunities in women’s health. Endocrinology 159, 2980–2990.
2. Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C.J., Estève, J., et al. (2018). Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391, 1023–1075.
3. Boér, K. (2016). Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer. Onco Targets Ther 9, 6119–6125.
4. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., and Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 1–31.
5. Brufsky, A.M., and Dickler, M.N. (2018). Estrogen receptor-positive breast cancer: Exploiting signaling pathways implicated in endocrine resistance. Oncologist 23, 528–539.
Cited by
228 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献